Bill > S2842

This bill aims to establish a comprehensive national screening and research program for congenital Cytomegalovirus (CMV), a viral infection that can cause serious health problems in newborns. The bill would require hospitals and healthcare facilities to test infants 21 days old or younger for CMV, with each state's chief health executive responsible for developing standards and procedures for testing, result tracking, and information dissemination. If a state fails to establish these protocols within two years, the Discretionary Advisory Committee on Heritable Disorders in Newborns and Children will develop and implement standards. The bill provides federal grant funding through three key agencies: the Health Resources and Services Administration (to support testing implementation), the Centers for Disease Control and Prevention (to improve data collection and provide education), and the National Institutes of Health (to conduct research on screening techniques, diagnostics, prevention, treatments, and potential vaccines). The bill also modifies the Advisory Committee's responsibilities to include overseeing CMV-related activities. Funding is authorized for fiscal years 2026 and 2027, with the goal of improving early detection, understanding, and management of congenital CMV.

Health and Social Services

https://www.congress.gov/bill/119th-congress/senate-bill/2842/all-info